Validation of the Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)

Documenti analoghi

• Health Status and Quality of Life in Patients With Stable Coronary Artery Disease and Chronic Kidney Disease Treated With Optimal Medical Therapy or Percutaneous Coronary Intervention (Post Hoc Findings from the COURAGE Trial)
  di: Sedlis, Steven P., et al.
  Pubblicazione: (2013)
• Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients: A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
  di: Acharjee, Subroto, et al.
  Pubblicazione: (2013)
• Frequency, Predictors and Consequences of Crossing Over to Revascularization within 12 months of Randomization to Optimal Medical Therapy in the COURAGE Trial
  di: Spertus, John A, et al.
  Pubblicazione: (2013)
• Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
  di: Sedlis, Steven P., et al.
  Pubblicazione: (2015)
• Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial)
  di: Padala, Santosh K., et al.
  Pubblicazione: (2015)